Alpha Cognition Inc. Fair Value, Concentration of Risk, Foreign Currency Contracts
Alpha Cognition Inc. (ACOG) had Fair Value, Concentration of Risk, Foreign Currency Contracts of CAD 154.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:FairValueConcentrationOfRiskForeignCurrencyContracts · last filed 2025-03-31
- 2024-12-31: Fair Value, Concentration of Risk, Foreign Currency Contracts 154.00K CAD.
- 2024-09-30: Fair Value, Concentration of Risk, Foreign Currency Contracts 31.00K CAD.
- 2024-06-30: Fair Value, Concentration of Risk, Foreign Currency Contracts 57.00K CAD.
- 2023-12-31: Fair Value, Concentration of Risk, Foreign Currency Contracts 36.00K CAD.
| Period end | Fair Value, Concentration of Risk, Foreign Currency Contracts |
|---|---|
| 2024-12-31 | 154.00K CAD 10-K · filed 2025-03-31 |
| 2024-09-30 | 31.00K CAD 10-Q · filed 2024-11-14 |
| 2024-06-30 | 57.00K CAD 10-Q · filed 2024-08-12 |
| 2023-12-31 | 36.00K CAD 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |